Literature DB >> 4299764

Hyperprolinaemia in two successive generations of a North American Indian family.

T L Perry, D F Hardwick, R B Lowry, S Hansen.   

Abstract

Mesh:

Substances:

Year:  1968        PMID: 4299764     DOI: 10.1111/j.1469-1809.1968.tb00573.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


× No keyword cloud information.
  8 in total

1.  Asymptomatic type II hyperprolinaemia associated with hyperglycinaemia in three sibs.

Authors:  L Pavone; F Mollica; H L Levy
Journal:  Arch Dis Child       Date:  1975-08       Impact factor: 3.791

2.  Incidence of cleft lip and palate in British Columbia Indians.

Authors:  R B Lowry; D H Renwick
Journal:  J Med Genet       Date:  1969-03       Impact factor: 6.318

Review 3.  Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour.

Authors:  R H Scott; C A Stiller; L Walker; N Rahman
Journal:  J Med Genet       Date:  2006-05-11       Impact factor: 6.318

4.  Hyperprolinaemia type I and white matter disease: coincidence or causal relationship?

Authors:  M Steinlin; E Boltshauser; B Steinmann; W Wichmann; G Niemeyer
Journal:  Eur J Pediatr       Date:  1989-10       Impact factor: 3.183

5.  Drug off-target effects predicted using structural analysis in the context of a metabolic network model.

Authors:  Roger L Chang; Li Xie; Lei Xie; Philip E Bourne; Bernhard Ø Palsson
Journal:  PLoS Comput Biol       Date:  2010-09-23       Impact factor: 4.475

6.  Increased prevalence of hereditary metabolic diseases among native Indians in Manitoba and northwestern Ontario.

Authors:  J C Haworth; L A Dilling; L E Seargeant
Journal:  CMAJ       Date:  1991-07-15       Impact factor: 8.262

7.  Type II hyperprolinaemia in a pedigree of Irish travellers (nomads).

Authors:  M P Flynn; M C Martin; P T Moore; J A Stafford; G A Fleming; J M Phang
Journal:  Arch Dis Child       Date:  1989-12       Impact factor: 3.791

8.  Biochemical and clinical features of hereditary hyperprolinemia.

Authors:  Hiroshi Mitsubuchi; Kimitoshi Nakamura; Shirou Matsumoto; Fumio Endo
Journal:  Pediatr Int       Date:  2014-08       Impact factor: 1.524

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.